SCHEMBL9531373

SCHEMBL9531373

CS(=O)(=O)c1ccc2c(O)c(-c3ccccc3)c(=O)n(Cc3ccc(-c4ccccc4-c4nnn[nH]4)cc3)c2c1

nearest known ligand 0.56

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 1/20 0.41
MAPK8 P45983 4/20 0.41
PTGS2 P35354 2/20 0.41
PTGS1 P23219 1/20 0.41
SRC P12931 2/20 0.41
PRKACA P17612 1/20 0.40
PRKACG P22612 1/20 0.40
PRKACB P22694 1/20 0.40
MAPK9 P45984 1/20 0.40
MAPK10 P53779 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9533159 0.87 KDM4E (0.39) SRC
SCHEMBL9531601 0.86 MAPK8 (0.43) EGLN1MAPK8
SCHEMBL9532793 0.85 KDM4E (0.39) EGLN1
SCHEMBL7435772 0.80 BCL2 (0.41)
SCHEMBL9262511 0.72 ALDH1A1 (0.39)
Bromide SCHEMBL9350589 0.72 CYP3A4 (0.41)
SCHEMBL9530986 0.71 AGTR1 (0.40)
SCHEMBL7322677 0.71 MAPT (0.39)
SCHEMBL9449474 0.70 AGTR1 (0.41)
SCHEMBL9308540 0.70 MEN1 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0572455-A1 SUBSTITUTED PYRIDINONES AND PYRIMIDINONES AS ANGIOTENSIN II ANTAGONISTS Astra Pharmaceuticals Limited (GB) 1993-12-08 EP claimed
WO-1992014714-A1 SUBSTITUTED PYRIDINONES AND PYRIMIDINONES AS ANGIOTENSIN II ANTAGONISTS FISONS PLC (GB) 1992-09-03 WO claimed
EP-0500297-A1 Substituted pyridinones and pyrimidinones as angiotensin II antagonists FISONS plc (GB) 1992-08-26 EP claimed
EP-0500297-A1 Substituted pyridinones and pyrimidinones as angiotensin II antagonists FISONS plc (GB) 1992-08-26 EP disclosed